| |
|
|
|
Keystone Symposia, Tahoe City, California
January 28 - February 1, 2007
This is a period of rapid progress for the field of anti-protozoal drug development. Genomic efforts have led to the identification of a myriad of new drug targets. Studies on the mechanisms of drug action and drug resistance have yielded new insights into how to improve on old agents. Promising development efforts span the spectrum from lead identification to clinical trials to registration. Key problems include target selection, drug development in an academia-centered environment, and performing trials in endemic areas. This meeting will bring together biologists and chemists with diverse backgrounds and scientists in academia and industry to work together towards solutions to these problems of global importance.
|
|
|
|
|
|
|
|
Organized by:
|
|
Daniel E. Goldberg, R. Kip Guy and Stephen A. Ward |
|
|
Invited Speakers:
|
|
- Kelly Chibale, University of Cape Town
- Norbert De Kimpe, Ghent University
- Maria Dias da Mota, Instituto Gulbenkian Ciência
- Domingo Gargallo-Viola, GlaxoSmithKline
- H. Göringer, Darmstadt University of Technology
- Jay Keasling, University of California, Berkeley
- Dennis Kyle, University of South Florida
- James McKerrow, University of California, San Francisco
- Sylke Muller, University of Glasgow
- James Sacchettini, Texas A & M University
- Arthur Strosberg, Institute for OneWorld Health
- Richard Tidwell, University of North Carolina
- Julio Urbina, Venezuelan Institute for Science Research
- Henri Vial, Universite Montpellier II
- Stephen Ward, University of Liverpool
- Peter Winstanley, University of Liverpool
- Yongyuth Yuthavong, Thai Academy of Science and Technology
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
Sept. 28, 2006
|
|
|
|
|
|
|
|
Registration:
|
|
Please see website
|
|
|
E-mail:
|
|
info@keystonesymposia.org
|
|
|
|
|
|
|
|
|